BI drug named Promising Innovative Medicine in mesotheliomaBoehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for Share XBI drug named Promising Innovative Medicine in mesotheliomahttps://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/
UK patients gain early access to Duchenne drugPatients to get Santhera’s Raxone under EAMS scheme. Share XUK patients gain early access to Duchenne drughttps://pharmaphorum.com/news/uk-patients-get-early-access-duchenne-drug/